Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

823
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
823
Cancer Prevention02:59

Cancer Prevention

8.7K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
8.7K
Cancer Prevention02:59

Cancer Prevention

3.0K
3.0K
Cancer Therapies02:49

Cancer Therapies

10.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K
Cancer Therapies02:49

Cancer Therapies

3.0K
3.0K
Cancer02:18

Cancer

55.6K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
55.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fertility drugs and breast and ovarian cancer.

Lancet (London, England)·1995
Same author

Cancer mortality in Europe, 1990-92.

European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)·1995
Same author

[Trends in skin cancers in the Vaud canton, 1976-1992].

Revue medicale de la Suisse romande·1995
Same author

Trends of skin cancer in the Canton of Vaud, 1976-92.

British journal of cancer·1995
Same author

Pancreatitis and the risk of pancreatic cancer.

Pancreas·1995
Same author

Mortality from benign prostatic hyperplasia: worldwide trends 1950-92.

Journal of epidemiology and community health·1995
Same journal

HER2-directed TAC T cells in solid tumors: a step forward, but not yet a therapeutic leap.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same journal

The ethical obligation to use positive trial results.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same journal

Lorlatinib: The Crown Jewel of ALK Inhibitors.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same journal

TROP2-Directed Antibody Drug Conjugates: New First-Line Treatment for All Patients with Advanced Triple-Negative Breast Cancer?

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same journal

When artificial intelligence learns to abstain: towards clinically responsible diagnostic support in liver pathology.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same journal

PRMT5 inhibitors in MTAP loss NSCLC with actionable genomic alterations: a new kid on the block?

Annals of oncology : official journal of the European Society for Medical Oncology·2026
See all related articles

Related Experiment Video

Updated: Mar 26, 2026

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
07:50

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study

Published on: April 18, 2025

1.2K

The global decrease in cancer mortality: trends and disparities.

D Hashim1, P Boffetta2, C La Vecchia3

  • 1Institute of Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, USA dana.hashim@mssm.edu.

Annals of Oncology : Official Journal of the European Society for Medical Oncology
|January 24, 2016
PubMed
Summary
This summary is machine-generated.

Global cancer mortality is decreasing, with millions of lives saved annually. However, rising liver and lung cancer deaths in women highlight urgent needs for targeted prevention and research.

Keywords:
cancerdata collection/standardsglobal healthmortalityregistries/standardsvital statistics

More Related Videos

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

6.3K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

1.0K

Related Experiment Videos

Last Updated: Mar 26, 2026

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
07:50

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study

Published on: April 18, 2025

1.2K
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

6.3K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

1.0K

Area of Science:

  • Global health
  • Epidemiology
  • Cancer research

Background:

  • Cancer mortality has declined in high-income nations over the past two decades.
  • Trends in low-to-middle income countries and globally remain unclear.

Purpose of the Study:

  • To compare cancer mortality rates across countries with reliable data.
  • To analyze trends from 2000 to 2010 for all cancers and common specific types.

Main Methods:

  • Descriptive study using World Health Organization (WHO) mortality database.
  • Included 60 countries with high- or intermediate-quality death certificate data.
  • Calculated age-adjusted mortality rates for combined and specific cancers (lung, stomach, breast, colorectal, uterine, prostate).

Main Results:

  • Overall cancer mortality decreased by approximately 1% annually in both sexes and across income regions.
  • An estimated 696,000 cancer deaths were averted globally in 2010 compared to 2000.
  • Increases in liver cancer mortality (both sexes) and female lung cancer mortality were observed in several countries.

Conclusions:

  • Individual cancer mortality risk has decreased globally in countries with reliable data.
  • Favorable trends in common cancers drove the overall mortality reduction.
  • Rising liver and female lung cancer mortality rates necessitate prioritized prevention and research efforts.